Treatment with Metformin Can Improve Insulin Resistance and Lipid Profile in Non-Diabetic Iraqi Women with Polycystic Ovary Syndrome

Background: Women with polycystic ovary syndrome (PCOS) are usually at increased risk of metabolic syndrome and insulin resistance (IR), regardless of their body weight, and the development of type 2 diabetes in those women is not uncommon. Metformin is an oral hypoglycemic drug with a significant r...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Ali M. Kadim Al-Tuma, Saba Sabeeh Hussain, Muhjah Falah Hassan
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wolters Kluwer Medknow Publications 2024-10-01
Saila:	Medical Journal of Babylon
Gaiak:	hba1c and lipid profile homa-ir metformin pcos
Sarrera elektronikoa:	https://doi.org/10.4103/MJBL.MJBL_913_23
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!